Mydecine Innovations Group Inc.
Mydecine Innovations Group is a life sciences company dedicated to the development and commercialization of adaptive pathway medicines, natural health products and digital health solutions.
Mydecine Innovations Group Inc. (MYCO)
Le 12 février/February 2021
Mydecine Innovations Group Inc. Warrants (the "Warrants") have been approved for listing.
Each Warrant shall, entitle the holder thereof to acquire one (1) Common Share after the Issue Date and prior to the Expiry Time, upon payment of the Exercise Price of $0.70.
See the Warrant Indenture for full details.
Les bons de souscription de Mydecine Innovations Group Inc. (les «bons de souscription») ont été approuvés pour inscription.